HKBU-led research team develops novel anti-viral targeted drug for nasopharyngeal cancer treatment
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first...
New HKBU-led study unveils COVID-19 transmission patterns and safety-conscious reopening plans
With the COVID-19 pandemic resulting in lockdowns in different parts of the world, from the US to many European nations, there have been intense debates on when and how we can safely reopen the economy. New research led by HKBU computer...
The new norm for post-pandemic teaching and learning
31 Jul 2020
HKBU aptamer research receives support from the Theme-based Research Scheme
28 Jul 2020
New book by staff (17 July 2020)
20 Jul 2020
HKBU researchers reveal education and career obstacles encountered by ethnic minority youth
15 Jul 2020
Research reveals greater flood risks due to slower tropical cyclone movement
15 Jul 2020
HKBU-led team receives support to study Pok Fu Lam fire dragon dance
07 Jul 2020